InvestorsHub Logo
Followers 7
Posts 285
Boards Moderated 0
Alias Born 04/11/2011

Re: None

Monday, 10/31/2016 3:41:46 PM

Monday, October 31, 2016 3:41:46 PM

Post# of 401499
Sent this to the editor at Fast Company.

I have an investment in a company called Elite Pharma.

The have a patent to stop abuse of opioids. They claim they stop the abuse of opioids by mixing the opioids with Narcan.

They coat the Narcan, mix it with an opoid. Taken properly the Narcan passes through and has no effect. Crush the pill to snort or inject and you only get the Narcan.

They went to FDA in 2014, stated here are the tests we have ran what else do you want. They ran that test, applied then got turned down July of this year.

The reason cited is that there is a chance to overdose if you take the opioids with a fatty meal. However, all currently approved drugs have the same exact problem, but no opioids abuse properties.

If Elites claims are true this stuff is cutting edge and needs to go forward, if not so be it. Elite claims it can do this patent with 17 different opioids.

Symbol is ELTP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News